PRESERVE

• Does Sodium Bicarbonate or Acetylcysteine prevent adverse outcomes after angiography?

AKI Outcomes

• Outcomes of AKI in Relation to Certain Prognostic Factors

IDEAL-ICU

• Is there an ideal time for initiation of RRT in patients with AKI or sepsis?

OPAL-HK

• Role of Patiromer in Patients with Kidney Disease

VA-NEPHRON D

• Is there a benefit of combination therapy with Ace and ARB for diabetic nephropathy?

Hyperkalemia Review Article

AKIKI

• Timing of RRT in patients with AKI in the ICU setting

Renal Failure in Cirrhosis Review Article

TREAT

• Darbepoetin Alpha in Patients with DM2 and CKD

Hyponatremia Review Article

RAVE

• Rituximab vs. Cyclophosphamide in ANCA-Associated Vasculitis

Normotensive Ischemic ARF Review Article

PIVOTAL

• IV Iron in Patients on Hemodialysis

IRMA-2

• Role of Irbesartan on the Development of Diabetic Nephropathy

CREDENCE

• Canagliflozin and Renal Outcomes in DM2 Patients

ALMS Induction for Lupus Nephritis

• Mycophenolate Mofetil vs. Cyclophosphamide for the Treatment of Lupus Nephritis